323 related articles for article (PubMed ID: 28620826)
1. Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.
Delic V; Griffin JWD; Zivkovic S; Zhang Y; Phan TA; Gong H; Chaput D; Reynes C; Dinh VB; Cruz J; Cvitkovic E; Placides D; Frederic E; Mirzaei H; Stevens SM; Jinwal U; Lee DC; Bradshaw PC
Neuromolecular Med; 2017 Sep; 19(2-3):322-344. PubMed ID: 28620826
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells.
Perfeito R; Ribeiro M; Rego AC
Arch Toxicol; 2017 Mar; 91(3):1245-1259. PubMed ID: 27424009
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ferritin protects SH-SY5Y cells against H
Guan H; Yang H; Yang M; Yanagisawa D; Bellier JP; Mori M; Takahata S; Nonaka T; Zhao S; Tooyama I
Exp Neurol; 2017 May; 291():51-61. PubMed ID: 28163159
[TBL] [Abstract][Full Text] [Related]
4. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells.
Perfeito R; Lázaro DF; Outeiro TF; Rego AC
Mol Cell Neurosci; 2014 Sep; 62():51-9. PubMed ID: 25109238
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.
Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P
Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457
[TBL] [Abstract][Full Text] [Related]
6. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
Lev N; Melamed E; Offen D
Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
[TBL] [Abstract][Full Text] [Related]
7. Low-Intensity Ultrasound Decreases α-Synuclein Aggregation via Attenuation of Mitochondrial Reactive Oxygen Species in MPP(+)-Treated PC12 Cells.
Karmacharya MB; Hada B; Park SR; Choi BH
Mol Neurobiol; 2017 Oct; 54(8):6235-6244. PubMed ID: 27714630
[TBL] [Abstract][Full Text] [Related]
8. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
Sánchez Campos S; Alza NP; Salvador GA
Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
[TBL] [Abstract][Full Text] [Related]
9. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons.
Ganjam GK; Bolte K; Matschke LA; Neitemeier S; Dolga AM; Höllerhage M; Höglinger GU; Adamczyk A; Decher N; Oertel WH; Culmsee C
Cell Death Dis; 2019 Nov; 10(11):865. PubMed ID: 31727879
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.
Musgrove RE; Helwig M; Bae EJ; Aboutalebi H; Lee SJ; Ulusoy A; Di Monte DA
J Clin Invest; 2019 Jun; 129(9):3738-3753. PubMed ID: 31194700
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers.
Dokleja L; Hannula MJ; Myöhänen TT
Neurosci Lett; 2014 Nov; 583():37-42. PubMed ID: 25240592
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
Devi L; Raghavendran V; Prabhu BM; Avadhani NG; Anandatheerthavarada HK
J Biol Chem; 2008 Apr; 283(14):9089-100. PubMed ID: 18245082
[TBL] [Abstract][Full Text] [Related]
15. Low-dose Cu exposure enhanced α-synuclein accumulation associates with mitochondrial impairments in mice model of Parkinson's disease.
Chen J; Gao X; Zheng C; Zhang C; Li P; He K; Liu G; Huang X; Liu J; Xie Y; Yang X
Toxicol Lett; 2023 Sep; 387():14-27. PubMed ID: 37717680
[TBL] [Abstract][Full Text] [Related]
16. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
Moussa CE; Wersinger C; Tomita Y; Sidhu A
Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
[TBL] [Abstract][Full Text] [Related]
17. Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase.
Ludtmann MH; Angelova PR; Ninkina NN; Gandhi S; Buchman VL; Abramov AY
J Neurosci; 2016 Oct; 36(41):10510-10521. PubMed ID: 27733604
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Sharma SK; Ebadi M
Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
